Dr. George F Murphy

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

GEORGE F. MURPHY, Chief of Dermatopathology

Address:

Brigham and Women's Hospital, Department of Pathology
75 Francis Street, Boston, MA

Medical School (including school name, date and degree awarded):

1972 MD, University of Vermont, Burlington, VT

Graduate Medical Education (including dates and institution of internship, residencies, fellowships, etc.):

1976-1977 Intern in Internal Medicine, Boston University Medical Center,
Boston, MA
1977-1980 Resident in Pathology, Massachusetts General Hospital, Boston, MA
1981-1982 Fellow in Dermatopathology, Massachusetts General Hospital, Boston, MA

Current Academic Appointment:

Professor of Pathology, Harvard Medical School

Current Medical Staff Appointment:

Chief of Dermatopathology, Brigham and Women's Hospital

Selected Bibliography:

Christofidou-Solomidou M, Albelda SM, Bennett FC, Murphy GF. Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras. Amer J Pathol 1997; 150:631-639.
Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Schultz L, Murphy GF, Whitaker-Menezes D, Stanley JR. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997; 137:1091-1102.
Tafuta T, Wu G, Murphy GF, Shapiro SS. Human ß-filamin: a new protein that interacts with the cytoplasmic tail of glycoprotein (Gp)Iba. J Biol Chem 1998; 273:17531-17538.
Schmaltz C, Alpdognan O, Muriglan SJ, Kappel BJ, Rotolo JA, Ongchin J, Crawford JM, Murphy GF, Yagita H, Walczak H, Peschon JJ, Van den Brink MRM. T cells require TRAIL for optimal graft-versus-tumor activity. Nature Med 2002, 8:1433-1437.
Whitaker-Menezes D, Jones SC, Friedman TM, Korngold R, Murphy GF. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression. Biol Blood Marrow Trans 2003, 9:559-570.
Elder DE, Eleneitsas R, Johnson B, Murphy GF. Lever’s Histopathology of the Skin, 9th edition,, Lippincott-Williams & Wilkins, Philadelphia, 2004